Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New developments in Sjögren's syndrome

E W St Clair1

  • 1Department of Medicine, Duke University Medical Center, Durham, NC 27710.

Current Opinion in Rheumatology
|September 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunoglobulin (Ig)M antibodies to proteinase 3 in granulomatosis with polyangiitis and microscopic polyangiitis.

Clinical and experimental immunology·2017
Same author

Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoids.

Arthritis & rheumatology (Hoboken, N.J.)·2015
Same author

Self-efficacy for exercise, more than disease-related factors, is associated with objectively assessed exercise time and sedentary behaviour in rheumatoid arthritis.

Scandinavian journal of rheumatology·2014
Same author

Rituximab for the treatment of relapses in antineutrophil cytoplasmic antibody-associated vasculitis.

Arthritis & rheumatology (Hoboken, N.J.)·2014
Same author

Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitis.

Arthritis and rheumatism·2013
Same author

Glycosylation of proteinase 3 (PR3) is not required for its reactivity with antineutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis.

Clinical and experimental rheumatology·2009
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

Sjögren's syndrome is a complex autoimmune condition affecting salivary and lacrimal glands. Research is exploring viral causes and improving diagnostics for better therapies.

Area of Science:

  • Immunology
  • Virology
  • Rheumatology

Background:

  • Sjögren's syndrome presents with diverse conditions like sicca manifestations and focal sialadenitis.
  • Lacrimal and salivary glands are targeted by viral, retroviral, lymphoproliferative, and autoimmune conditions, triggering local immune responses.
  • Understanding Sjögren's syndrome heterogeneity is crucial for advancing research.

Purpose of the Study:

  • To investigate the heterogeneous nature of Sjögren's syndrome.
  • To explore potential viral or retroviral etiologies.
  • To address challenges in diagnostic testing and classification of Sjögren's syndrome.

Main Methods:

  • Review of existing literature on sicca manifestations and focal sialadenitis.
  • Analysis of immune responses targeting lacrimal and salivary glands.

Related Experiment Videos

  • Discussion of current diagnostic and classification challenges.

    • Main Results:

    • Growing evidence links various conditions to Sjögren's syndrome, highlighting its complexity.
    • Viral and retroviral infections are increasingly considered as potential triggers.
    • Significant challenges persist in developing accurate diagnostic tools and classification criteria.

    Conclusions:

    • A deeper understanding of Sjögren's syndrome is essential.
    • Further research into viral causes and improved diagnostic methods are needed.
    • Development of innovative and effective therapies requires comprehensive knowledge of the syndrome's mechanisms.